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Abstract  
Leiomyosarcoma of the genitourinary tract is 
a rare malignancy generally having a poor 
prognosis, with scarce literature having been 
published. This case report outlines the clinical 
progression of a 43year old that presented with 
macroscopic haematuria and was subsequently 
diagnosed with leiomyosarcoma of the distal ureter.  
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Introduction 
Leiomyosarcoma of the ureter is an 
uncommon urological malignancy which is as yet 
rather poorly understood, with consequent scant 
coverage in current literature. This malignancy has 
been always associated with a poor prognosis, 
although 5-year survival rates have improved over 
the years.  The following describes a ureteric 
leiomyosarcoma in a 43-year-old woman. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The patient is a 43-year-old lady with no 
previous medical history who presented to the 
emergency department with a one-month history of 
loin to groin pain radiating to the back and over 10 
episodes of haematuria with clots in the previous 
two months. An ultrasound of the urinary tract 
showed severe hydronephrosis of the left kidney 
with a hydroureter that could be followed down to 
the bladder. This was followed up by a non-contrast 
CT scan that identified a well-defined, lobulated 
soft tissue mass at the left vesicoureteric junction 
that was causing the ureteric obstruction (Figure 1). 
 
Figure 1: well-defined, lobulated soft tissue mass at 
the left vesicoureteric junction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
At cystoscopy, a soft tissue mass originating 
from the left distal ureter and involving the bladder 
wall in the vicinity of the ureteric orifice was 
resected and the left ureter was stented with a 
double J stent.  An initial diagnosis of high grade 
urothelial carcinoma involving the muscle wall 
(pT2G3 WHO classification 1973) was made on 
histological examination of the resected tissue.  A 
positron emission tomography scan using 
fludeoxyglucose tracer did not show any regional or 
distant metastases. Because of the exceedingly rare 
incidence of these tumours, a specific staging 
system for sarcomas of the ureter does not exist and 
the TNM staging for transitional cell carcinoma of 
the ureter is used as published by the American 
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Joint Committee on Cancer in 2009. Clinical 
staging of our patient using this system would be 
T2N0M0 at presentation.  
After discussion at a multi-disciplinary 
meeting it was decided to proceed to open left 
nephroureterectomy. On histological examination of 
the operative specimen, the diagnosis was revised to 
pleomorphic leiomyosarcoma (Figure 2) obstructing 
the ureter with invasion of the bladder wall (with 
positive surgical margins). 
 
Figure 2: Pleomorphic tumor composed of 
irregular sheets of poorly-differentiated neoplastic 
cells with occasional bizarre nuclei which are SMA 
and CD99 positive, p63, CK7, CK20, Desmin, 
HHF-35, CD117 and CD34 negative. (HE stain, 
x200) 
 
 
 
 
 
 
 
 
 
 
 
The patient presented again a year after her 
surgery with multiple episodes of haematuria. CT 
scan showed locally recurrent disease with another 
lobulated mass close to the original site of the left 
ureteric orifice with extensive involvement of the 
bladder wall (Figure 3). Repeat transurethral 
resection and histological examination confirmed 
recurrence of the original disease process.   
 
Figure 3: CT showing local recurrence of disease 
 
 
 
Repeat fludeoxyglucose PET scanning this 
time showed multiple metastases to liver and lung 
(Figure 4), consequently ifosfamide and epirubicin 
chemotherapy was commenced. 
 
Figure 4: PET imaging showing liver involvement 
by disease 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This was shortly followed by an episode of 
severe haematuria requiring multiple blood 
transfusions and bilateral embolization of the 
anterior division of the iliac arteries. Local pelvic 
progression of the malignant process resulted in 
contralateral renal obstruction and renal failure 
which was treated with percutaneous nephrostomy 
diversion, followed by pelvic external beam 
radiotherapy in an effort to control local symptoms. 
Over the following 6 months, the patient was 
admitted multiple times for blood transfusions 
following recurrent episodes of gross intractable 
haematuria, progressive general deterioration and 
renal dysfunction eventually resulting in death. 
 
Discussion 
Soft tissue sarcomas are the commonest 
mesenchymal tumors of the urinary tract, 
accounting for 1-2% of malignant genitourinary 
tumors and 2.1% of all sarcomas,1 with 
leiomyosarcomas comprising 50% of cases, 
rhabdomyosarcomas 20% and the rest being rare 
histological subtypes.2 In view of the rarity of this 
malignancy, published literature on the subject is 
scarce. Understanding of the etiology and 
pathogenesis of the disease is rather limited, with 
retinoblastoma 1 gene mutation, previous pelvic 
radiotherapy and use of cyclophosphamide being 
considered as likely aetiological agents.3-4  
Most case reports published to date have 
involved young female patients, however with less 
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than 20 cases documented in the literature it is 
difficult to establish definitive epidemiological 
patterns. 
Most data available pertains to the prognosis 
of the disease, derived from several case series and 
multicentre studies over the years.4-6 Mackenzie et 
al in 1968 reported that the disease has a poor 
prognosis, with 10% 3-year overall survival7. 
Survival has improved over the years with recent 
studies reporting 5-year disease specific survival in 
the order of 55 – 60%, most likely related to early 
diagnosis with the more frequent use of cross 
sectional imaging.5-7 The most important factors 
determining prognosis are metastases at 
presentation and free margins on surgical resection.2 
Rosser et al showed that the most common 
symptoms at presentation are gross hematuria (81% 
of patients), followed by increased urinary 
frequency (28%), and dysuria (19%).8 As diagnosis 
is often late, with less than 15% of patients 
presenting at T1 clinical stage.9 Indeed, our patient 
was staged at T2 at presentation, patients presenting 
with muscle invasive disease are considered to have 
locally advanced disease and invariably their 
prognosis is poor. 
As no randomized controlled trials comparing 
treatment options in leiomyosarcoma of the urinary 
tract have ever been published, treatment is largely 
empirical, with extrapolation of methods used in 
treatment of epithelial tumors of the ureter. In the 
above case, surgical excision of the kidney, 
neighboring lymph nodes and ureter was 
performed.10 
In addition to this, the role of adjuvant 
chemotherapy using multimodal sarcoma 
chemotherapy protocols using doxorubicin or 
epirubicin, ifosfamide, cisplatinum and docetaxel 
and external beam radiotherapy have also been 
advocated, especially in cases of partial 
cystectomy.5  
Spiess et al (2007) showed that local 
recurrences occur in about 16% of cases, whereas 
metastases, most commonly in lung, liver brain and 
bone, occur in 53% of cases. In metastatic disease, 
chemoradiation remains the only palliative option 
available in patients with good performance status 
who can tolerate such regimens.5  
This case report outlines the salient features of 
leimyosarcoma of the ureter and adds to the 
published literature on such a rare entity, which 
should be part of the differential diagnosis in 
patients presenting with soft tissue masses in the 
region, especially in young female patients. 
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